Bumetanide; sex-biased gene expression; racial and ethnic disparities

Here is a roundup of autism-related news and research spotted around the web for the week of 15 July.

  • A population-based assessment of conditions linked to recurrent copy number variants shows a lower likelihood of having autism, attention-deficit/hyperactivity disorder or schizophrenia than do previous estimates based on case-control studies. JAMA Psychiatry
  • Sex-biased gene expression in several regions of the rhesus monkey brain is regulated by sex hormones. Expression patterns are similar to those of humans. Cell Genomics
  • Parent-infant interactions—particularly the baby’s attentiveness to their parent—at ages 8 and 14 months appear to be predictive of autism diagnosis at 3 years. Autism Research
  • Bumetanide, a diuretic drug that blocks NKCC1 chloride transport proteins, mitigates the altered neuronal activity and sensory hypersensitivity that occurs in a mouse model of fragile X syndrome. Biological Psychiatry
  • Researchers returned results on a genetic analysis of autism-linked genes in a cohort of 21,532 autistic people. Genetic in Medicine
  • Autistic children are more likely than their non-autistic peers to have physical and mental health problems; those from minoritized racial and ethnic groups tend to have even poorer outcomes. Journal of Child and Adolescent Psychopharmacology

Sign up for the weekly Spectrum newsletter to stay current with the latest advancements in autism research.